Skip to main content

05.06.2018 | Bone Marrow and Adipose Tissue (G Duque and B Lecka-Czernik, Section Editors) | Ausgabe 4/2018

Current Osteoporosis Reports 4/2018

The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone

Current Osteoporosis Reports > Ausgabe 4/2018
Jonathan D. Diedrich, Mackenzie K. Herroon, Erandi Rajagurubandara, Izabela Podgorski
Wichtige Hinweise
This article is part of the Topical Collection on Bone Marrow and Adipose Tissue


Purpose of Review

Bone marrow adipocytes have emerged in recent years as key contributors to metastatic progression in bone. In this review, we focus specifically on their role as the suppliers of lipids and discuss pro-survival pathways that are closely linked to lipid metabolism, affected by the adipocyte-tumor cell interactions, and likely impacting the ability of the tumor cell to thrive in bone marrow space and evade therapy.

Recent Findings

The combined in silico, pre-clinical, and clinical evidence shows that in adipocyte-rich tissues such as bone marrow, tumor cells rely on exogenous lipids for regulation of cellular energetics and adaptation to harsh metabolic conditions of the metastatic niche. Adipocyte-supplied lipids have a potential to alter the cell’s metabolic decisions by regulating glycolysis and respiration, fatty acid oxidation, lipid desaturation, and PPAR signaling. The downstream effects of lipid signaling on mitochondrial homeostasis ultimately control life vs. death decisions, providing a mechanism for gaining survival advantage and reduced sensitivity to treatment.


There is a need for future research directed towards identifying the key metabolic and signaling pathways that regulate tumor dependence on exogenous lipids and consequently drive the pro-survival behavior in the bone marrow niche.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Nicht verpassen: e.Med bis 22. Oktober 100 € günstiger.

Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

Current Osteoporosis Reports 4/2018Zur Ausgabe

Epidemiology and Pathophysiology (F Cosman and D Shoback, Section Editors)

Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures

Craniofacial Skeleton (WE Roberts, Section Editor)

Part I: Development and Physiology of the Temporomandibular Joint

Orthopedic Management of Fractures (S Bukata and L Gerstenfeld, Section Editors)

Origin of Reparative Stem Cells in Fracture Healing

Orthopedic Management of Fractures (S Bukata and L Gerstenfeld, Section Editors)

Recent Advances and Future of Gene Therapy for Bone Regeneration

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Orthopädie und Unfallchirurgie und bleiben Sie gut informiert – ganz bequem per eMail.